content_image/61673.jpg content_image/61671.jpg
## Selected Operating Trends 

<img src='content_image/61673.jpg'>

N.M.- Not Meaningful 

$^{(1) }$Effect of special charges includes merger-related costs, other special charges and pro forma adjustment. See “Management’ Discussion and Analysis of Financial Condition and Results of Operations” and Note 2 of “Notes to Consolidated Financial Statements” for further analysis. 

## Management’ Discussion and Analysis of Financial Condition and Results of Operations 

## General 

The Company operates within four operating business segments: Phar maceutical Distribution and Provider Services, Medical-Surgical Products and Services, Pharmaceutical T echnologies and Services and Automation and Information Services. See Note 12 of “Notes to Consolidated Financial Statements” for a description of these segments and a discussion of the Company’s change in operating segments. 

## Results of Operations 

## Operating Revenue 

<img src='content_image/61671.jpg'>

$^{(1) }$The growth rate applies to the respective fiscal year as compared to the prior fiscal year. 

